Skip to main content
All lobbying filings

LMH STRATEGIC SOLUTIONS

Lobbying for PTC THERAPEUTICS, INC. · Biopharmaceutical company.

 Filing Registration
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · posted May 8, 2025

Official filing document

 Bills named in this filing 1
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
 Lobbying activity 3
Taxation/Internal Revenue Code

Legislation issues impacting PTC Therapeutics, including: H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. MVP Act. Tax Relief for American Families and Workers Act. American Innovation and Jobs Act. ORPHAN Cures Act. American Innovation and R&D Competitiveness Act. Camerons Law.

Medicare/Medicaid

Legislation issues impacting PTC Therapeutics, including: H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. MVP Act. Tax Relief for American Families and Workers Act. American Innovation and Jobs Act. ORPHAN Cures Act. American Innovation and R&D Competitiveness Act. Camerons Law.

Health Issues

Legislation issues impacting PTC Therapeutics, including: H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. MVP Act. Tax Relief for American Families and Workers Act. American Innovation and Jobs Act. ORPHAN Cures Act. American Innovation and R&D Competitiveness Act. Camerons Law.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem